Pluri (PLUR) Interest Coverage Ratio (2011 - 2025)
Pluri (PLUR) posted quarterly Interest Coverage Ratio of 28.16 for Q4 2025, down 19.89% year-over-year from 35.16 in Q4 2024, and down 1.57% quarter-over-quarter from 27.73 in Q3 2025.
Pluri (PLUR) Interest Coverage Ratio (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Interest Coverage Ratio for 15 consecutive years, with 28.16 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 19.89% year-over-year to 28.16; the TTM figure through Dec 2025 stood at 27.49 (down 9.08% YoY), while the FY2025 annual figure was 0.31, up 98.8% from the prior year.
- Interest Coverage Ratio retreated to 28.16 in Q4 2025 per PLUR's latest filing, from 27.73 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 9.16 in Q2 2022 and bottomed at 92.32 in Q2 2021.
- Historically, Interest Coverage Ratio has averaged 34.97 across 5 years, with a median of 28.29 in 2025.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 90.08% — and 2023, when it tumbled 224.85%.
- Pluri's Interest Coverage Ratio stood at 47.98 in 2021, then soared by 34.33% to 31.5 in 2022, then advanced by 23.39% to 24.13 in 2023, then increased by 2.66% to 23.49 in 2024, then declined by 19.89% to 28.16 in 2025.
- Business Quant data shows PLUR's Interest Coverage Ratio at 28.16 in Q4 2025, 27.73 in Q3 2025, and 28.42 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Pluri | 16.11 Mn | 3.63 Mn | 86,000.00 | -28.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.16 |
| Sep 30, 2025 | -27.73 |
| Jun 30, 2025 | -28.42 |
| Mar 31, 2025 | -25.47 |
| Dec 31, 2024 | -23.49 |
| Sep 30, 2024 | -23.95 |
| Jun 30, 2024 | -27.68 |
| Mar 31, 2024 | -14.19 |
| Dec 31, 2023 | -24.13 |
| Sep 30, 2023 | -25.13 |
| Jun 30, 2023 | -29.75 |
| Mar 31, 2023 | -32.72 |
| Dec 31, 2022 | -31.50 |
| Sep 30, 2022 | -35.69 |
| Jun 30, 2022 | -9.16 |
| Mar 31, 2022 | -46.97 |
| Dec 31, 2021 | -47.98 |
| Sep 30, 2021 | -50.18 |
| Jun 30, 2021 | -92.32 |
| Mar 31, 2021 | -74.87 |